011dkk
-0,9 %
Date:2025-10-31Time:17:20:00Latest report:Q2-2025List:Small CapTicker:PEG
Market Cap:131 mdkkEnterprise Value:149 mdkkNet Sales:- mdkkEarnings:-20,9 mdkkEmployees:0ISIN:DK0061155009

Ratios

10-year key figure history for Pharma Equity turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Pharma Equity with index and moving average MA50 and MA200.

Stockprice:0,11
MA50:0,12
MA200:0,12
Price/MA200:-13,1 %
RSI (14):46,3
Price/MA50:-11,5 %

Description

Pharma Equity Group develops medicines for the treatment of serious and life-threatening inflammatory diseases for which there is currently no adequate treatment. The Company uses repositioning of existing medicines and takes drug candidates to a clinical Phase III stage, after which they are handed over to a strategic partner who will complete the development of the products and bring them to market, either independently or in collaboration with the Company.

Holding Companies